FDA Drugs recall ·
fentaNYL Citrate Injectable Solution, Narcotic, CII… recall
- Recall number
- D-0505-2026
- Date
- (initiated April 1, 2026)
- Company / brand
- Wells Pharma of Houston LLC
9265 Kirby Dr, Houston, TX, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 50 syringes
- Hazard tags
- Manufacturing practices (cGMP)
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
Why was it recalled?
cGMP deviations.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot 011226204250063, Exp Date 05/14/2026
Distribution
U.S. Nationwide.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0505-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.